Latest accounts payable for ISCNF: $400K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Isracann Biosciences (ISCNF) currently reports a accounts payable of $400K as of August 2022. That compares with $450K in the prior-year period — down 10.7% year over year. Use the charts on this page to explore Isracann Biosciences's accounts payable history and peer comparisons.
Isracann Biosciences's accounts payable decreased from $450K to $400K — a 10.7% year-over-year decrease (period ending August 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Isracann Biosciences reported $400K in accounts payable as of August 2022. That compares with $450K in the prior-year period — down 10.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $400K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Isracann Biosciences, and consider following ISCNF for alerts when major investors trade the stock.